Two weeks ago, I put out an article on GLP-1 medications and why they will be the most critical intervention of the last decade, and likely the coming decade
Conner Mertens 04:46 Yeah, theres a lot of ambiguity and like we said, just a lack of transparency overall
Improvising a schedule to smooth out side effects is understandable, but it substitutes a regimen nobody has studied for one that carries an evidence base
3,19,20 They stimulate satiety , the sense of feeling full after a meal, reducing cravings and caloric intake.GLP-1 agonists are approved for use in some people with type II diabetes, and two of them are FDA-approved for weight loss in certain people and situations
Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the global burden of disease study 2019
Of course, the satire cuts deeper than just the drugs themselves critique of the American healthcare system plays a major role